Natriumklorid Viaflo Baxter (Sodium Chloride)

Natriumklorid Viaflo Baxter is used in clinical situations that require rapid restoration of extracellular fluid volume and electrolyte balance.

• Fluid replacement: restores circulating volume in patients with blood loss or dehydration.
• Electrolyte imbalance correction: normalizes sodium and chloride concentrations in patients with hyponatremia or chloride deficits.
• Hypovolemia: expands intravascular volume to improve tissue perfusion in shock or severe fluid loss.

• The isotonic sodium chloride solution directly enters the extracellular compartment, increasing osmotic pressure and drawing water into the vascular space. This raises plasma sodium and chloride concentrations, expands intravascular volume, and improves hemodynamic parameters without requiring metabolic conversion, providing immediate resuscitation of fluid deficits.

Intravenous sodium chloride may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Phlebitis at the infusion site
• Local infiltration or edema
• Mild hypernatremia
• Transient hypertension
• Nausea or vomiting

Serious or Rare Side Effects

• Severe hypernatremia leading to neurologic symptoms
• Pulmonary edema in patients with cardiac dysfunction
• Anaphylactoid reaction or severe allergic response
• Hyperchloremic metabolic acidosis (rare)
• Air embolism if line not properly primed

When using Natriumklorid Viaflo Baxter, clinicians should observe several safety measures to minimise risks.

• Assess volume status: evaluate cardiac and renal function before infusion.
• Monitor serum electrolytes: check sodium and chloride levels during therapy.
• Use aseptic technique: ensure sterile connection to prevent infection.
• Check compatibility: avoid mixing with drugs that may precipitate.
• Adjust infusion rate: tailor speed to patient’s hemodynamic condition.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Sodium chloride infusion can interact with other intravenous therapies, influencing fluid balance or drug stability.

Major Interactions (Avoid)

• Co‑administration of large volumes of other IV crystalloids: risk of fluid overload.
• Concurrent high‑dose potassium chloride infusions without monitoring: may cause dangerous hyperkalemia.
• Simultaneous infusion of calcium‑containing solutions: can lead to precipitation.

Moderate Interactions (Monitor Closely)

• Blood products: may cause hemolysis if mixed directly.
• Certain antibiotics (e.g., ceftriaxone): may have reduced stability when mixed.
• Diuretics: may amplify electrolyte shifts, requiring closer lab monitoring.
• Inhaled bronchodilators with nebulised saline: may increase airway irritation.